BUZZ · Exit · 1d
weight 0.420% → 0 (exited)·stock up 0.3% in the 30 days before
Oct 15·entry $56.00·now $54.17
TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody.
Close · 3M
+7.69%
None of the tracked AI ETFs currently hold this name.
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
BUZZ · Exit · 1d
weight 0.420% → 0 (exited)·stock up 0.3% in the 30 days before
Oct 15·entry $56.00·now $54.17
BUZZ · Accumulation · 5d
weight 0.390% → 0.420% (+0.030 pp)·stock up 2.5% in the 30 days before
Oct 14·entry $54.37·now $54.17Fresh
BUZZ · Weight increase · 4d
weight 0.370% → 0.410% (+0.040 pp)·stock up 2.6% in the 30 days before
Oct 12·entry $55.27·now $54.17Fresh
BUZZ · Weight increase · 3d
weight 0.370% → 0.400% (+0.030 pp)·stock down 0.0% in the 30 days before
Oct 9·entry $55.37·now $54.17Fresh
BUZZ · Weight increase · 2d
weight 0.370% → 0.390% (+0.020 pp)·stock down 2.4% in the 30 days before
Oct 8·entry $53.34·now $54.17Fresh
BUZZ · Weight increase · 2d
weight 0.350% → 0.420% (+0.070 pp)·stock up 12.4% in the 30 days before
Sep 17·entry $56.47·now $54.17Fresh
BUZZ · Weight decrease · 2d
weight 0.370% → 0.350% (-0.020 pp)·stock up 13.0% in the 30 days before
Sep 7·entry $55.74·now $54.17
BUZZ · Weight increase · 2d
weight 0.330% → 0.370% (+0.040 pp)·stock down 0.1% in the 30 days before
Aug 24·entry $56.01·now $54.17Fresh
BUZZ · Weight decrease · 2d
weight 0.370% → 0.340% (-0.030 pp)·stock down 15.0% in the 30 days before
Aug 13·entry $47.94·now $54.17
BUZZ · Weight decrease · 3d
weight 0.450% → 0.360% (-0.090 pp)·stock down 13.4% in the 30 days before
Aug 3·entry $46.17·now $54.17
BUZZ · Weight decrease · 2d
weight 0.450% → 0.410% (-0.040 pp)·stock down 2.8% in the 30 days before
Jul 31·entry $52.03·now $54.17
BUZZ · Weight increase · 2d
weight 0.400% → 0.450% (+0.050 pp)·stock up 4.6% in the 30 days before
Jul 24·entry $56.04·now $54.17Fresh
BUZZ · Weight decrease · 3d
weight 0.430% → 0.400% (-0.030 pp)·stock down 3.2% in the 30 days before
Jul 22·entry $52.68·now $54.17
BUZZ · Weight decrease · 2d
weight 0.430% → 0.410% (-0.020 pp)·stock up 1.4% in the 30 days before
Jul 21·entry $53.95·now $54.17
BUZZ · Weight decrease · 2d
weight 0.460% → 0.440% (-0.020 pp)·stock up 18.0% in the 30 days before
Jul 13·entry $55.01·now $54.17
BUZZ · Weight increase · 2d
weight 0.420% → 0.460% (+0.040 pp)·stock up 43.1% in the 30 days before
Jul 7·entry $58.06·now $54.17Fresh
BUZZ · Weight decrease · 2d
weight 0.450% → 0.420% (-0.030 pp)·stock up 44.8% in the 30 days before
Jun 30·entry $54.94·now $54.17
BUZZ · Weight increase · 3d
weight 0.400% → 0.430% (+0.030 pp)·stock up 37.9% in the 30 days before
Jun 24·entry $53.60·now $54.17Fresh
BUZZ · Weight increase · 2d
weight 0.400% → 0.420% (+0.020 pp)·stock up 37.5% in the 30 days before
Jun 23·entry $53.94·now $54.17Fresh
BUZZ · Accumulation · 5d
weight 0.360% → 0.470% (+0.110 pp)·stock up 30.4% in the 30 days before
Jun 17·entry $51.50·now $54.17Drifting
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.